TLDR
- ARK Invest sold 134,472 Coinbase shares worth $19.6 million after the stock rallied 13% on Friday
- Wood bought 31,505 Alphabet shares valued at $10.4 million following a 2.5% decline related to capital spending concerns
- ARK purchased 393,057 Bullish shares for $9.8 million, continuing to build its crypto exchange position
- The fund added 630,920 Recursion Pharmaceuticals shares worth $2.2 million to boost biotech exposure
- ARK also sold 141,930 Roku shares for $12.2 million, continuing its reduction in the streaming platform
Cathie Wood’s ARK Invest disclosed portfolio changes on Friday, February 6, 2026, showing strategic moves across tech and crypto sectors. The trading activity revealed a pattern of profit-taking in rallying stocks while adding to positions experiencing temporary weakness.
The largest transaction involved Coinbase Global. ARK sold 134,472 shares worth approximately $19.6 million.
The sale came after Coinbase stock jumped roughly 13% on Friday. The rally was driven by Bitcoin prices moving higher after touching $60,000 the previous day.
ARK has been reducing its Coinbase position over recent days. The latest sale continues this trend of trimming the crypto exchange holding.
On the buying side, Wood purchased 31,505 Alphabet shares. The purchase was valued at approximately $10.4 million.
Alphabet stock closed 2.5% lower on Friday at $165.12. The decline followed the company’s announcement of higher capital spending guidance.
Wood appears to be buying the technology dip. The purchase suggests confidence in Alphabet’s long-term artificial intelligence and cloud computing prospects.
ARK Expands Crypto Exchange Position
ARK acquired 393,057 shares of Bullish for roughly $9.8 million. The purchase came as cryptocurrency prices declined.
Wood has been building this position since Bullish’s initial public offering in August 2025. The consistent buying pattern indicates strong conviction in the crypto exchange platform.
The Bullish purchases were spread across various ARK ETFs. This represents one of the fund’s larger acquisitions for the day.
Healthcare and Biotech Additions
ARK bought 630,920 shares of Recursion Pharmaceuticals. The purchase totaled approximately $2.2 million.
Recursion focuses on AI-driven drug discovery. The acquisition adds to ARK’s exposure in the biotechnology sector.
Wood also purchased 56,187 shares of TharImmune. The smaller biotech position was valued at roughly $221,000.
These healthcare additions demonstrate ARK’s continued interest in companies using artificial intelligence. The fund has maintained focus on innovative drug development platforms.
ARK sold 7,097 shares of Guardant Health for about $698,000. This sale is part of an ongoing reduction in the company.
Streaming Platform Reduction Continues
The fund sold 141,930 Roku shares valued at roughly $12.2 million. This extends ARK’s earlier reductions in the streaming platform.
Roku has been among the positions ARK has been trimming throughout the week. The sales indicate a shift in conviction for the streaming sector.
The trades for February 6 show ARK managing positions actively across sectors. Wood’s strategy involves taking profits in stocks experiencing short-term strength while adding to positions with long-term potential during price weakness.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
